Amiodarone deposition in the liver
Updates to Article Attributes
Amiodarone deposition in the liver is one of the complications that can occur with amiodarone therapy.
Terminology
Increased density in the liver in patients treated with amiodarone is often described in the literature as amiodarone hepatotoxicity, however it is often an incidental finding with no symptoms or signs of liver diseaseref.
Clinical presentation
In the majority of patients, it is discovered incidentally during routine testing of liver biochemistry and rarely do the hepatic effects develop into symptomatic liver injury or failure 1-5.
Radiographic features
CT
While being non-specific, increased hepatic attenuation has been described as one of the effects of amiodarone on the liver 2,3. This, however, may not necessarily imply hepatotoxicity.
There is no published literature showing that dronedarone, a synthetic derivative of amiodarone, produces similar CT appearances. This is likely due to the absence of the iodine moieties in the dronedarone molecule. Nevertheless dronedarone can produce severe hepatotoxicity 6.
See also
-<p><strong>Amiodarone deposition in the liver</strong> is one of the complications that can occur with <a href="/articles/amiodarone">amiodarone</a> therapy. </p><h4>Terminology</h4><p>Increased density in the liver in patients treated with amiodarone is often described in the literature as amiodarone hepatotoxicity, however it is often an incidental finding with no symptoms or signs of liver disease.</p><h4>Clinical presentation</h4><p>In the majority of patients, it is discovered incidentally during routine testing of liver biochemistry and rarely do the hepatic effects develop into symptomatic liver injury or failure <sup>1-5</sup>. </p><h4>Radiographic features</h4><h5>CT </h5><p>While being non-specific, <a href="/articles/hepatic-attenuation-on-ct">increased hepatic attenuation</a> has been described as one of the effects of amiodarone on the liver <sup>2,3</sup>. This, however, may not necessarily imply hepatotoxicity.</p><p>There is no published literature showing that dronedarone, a synthetic derivative of amiodarone, produces similar CT appearances. This is likely due to the absence of the iodine moieties in the dronedarone molecule. Nevertheless dronedarone can produce severe hepatotoxicity <sup>6</sup>.</p><h4>See also</h4><ul><li><a href="/articles/amiodarone-lung-1">amiodarone lung</a></li></ul>- +<p><strong>Amiodarone deposition in the liver</strong> is one of the complications that can occur with <a href="/articles/amiodarone">amiodarone</a> therapy. </p><h4>Terminology</h4><p>Increased density in the liver in patients treated with amiodarone is often described in the literature as <strong>amiodarone hepatotoxicity</strong>, however it is often an incidental finding with no symptoms or signs of liver disease <sup>ref</sup>.</p><h4>Clinical presentation</h4><p>In the majority of patients, it is discovered incidentally during routine testing of liver biochemistry and rarely do the hepatic effects develop into symptomatic liver injury or failure <sup>1-5</sup>. </p><h4>Radiographic features</h4><h5>CT </h5><p>While being non-specific, <a href="/articles/hepatic-attenuation-on-ct">increased hepatic attenuation</a> has been described as one of the effects of amiodarone on the liver <sup>2,3</sup>. This, however, may not necessarily imply hepatotoxicity.</p><p>There is no published literature showing that dronedarone, a synthetic derivative of amiodarone, produces similar CT appearances. This is likely due to the absence of the iodine moieties in the dronedarone molecule. Nevertheless dronedarone can produce severe hepatotoxicity <sup>6</sup>.</p><h4>See also</h4><ul><li><a href="/articles/amiodarone-lung-1">amiodarone lung</a></li></ul>
Unable to process the form. Check for errors and try again.